Medtronic's Jason Fontana offers an update on next-generation Symplicity Spyral devices, procedures and a new feature they're ...

Analysts are optimistic about Medtronic (MDT) after the Centers for Medicare and Medicaid Services (CMS) proposed to cover ...

On Thursday, the US Centers for Medicare & Medicaid Services (CMS) issued its proposal for covering radiofrequency- or ...

The patented method uses genetic markers and a weighted algorithm to assess the responsiveness to renal denervation.

Medtronic and Recor Medical both issued statements supporting new Medicare coverage for their respective renal denervation ...

About the Paradise Ultrasound Renal Denervation System The Paradise uRDN system is a first-of-its-kind ultrasound-based RDN ...

Medtronic is studying the use of its nitinol-enabled Symplicity Spyral renal denervation (RDN) catheter combined with hepatic ...

The Symplicity studies suggest that intravascular renal sympathetic nervous denervation improves blood pressure in patients with resistant hypertension, thus potentially opening a market for ...

Between 6 June 2007 and 1 May 2010, the Symplicity HTN-1 investigators applied renal sympathetic denervation in 153 patients, [13] including the 45 patients from the Symplicity HTN-1 study. [11] ...

Biffi A, Dell’Oro R, Quarti-Trevano F, Corrao G, Mancia G, Grassi G. Effects of renal denervation on sympathetic nerve traffic and correlates in drug-resistant and uncontrolled hypertension: a ...

Letter by Zhang and Zhong Regarding Article, “Effects of Catheter-Based Renal Denervation in Hypertension: A Systematic Review and Meta-Analysis” ...